title: Granulocyte colony-stimulating factor: effective in ameliorating fluorouracil-based myelosuppression?
authors.affiliation: Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
authors.forename: K
authors.initials: K
authors.lastname: Christman
authors.forename: L
authors.initials: L
authors.lastname: Saltz
authors.forename: G
authors.initials: G
authors.lastname: Schwartz
authors.forename: C
authors.initials: C
authors.lastname: Friedrich
authors.forename: D
authors.initials: D
authors.lastname: Kelsen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001853:Bone Marrow / Q000187:drug effects*; D004317:Doxorubicin / Q000009:adverse effects; D005472:Fluorouracil / Q000009:adverse effects*; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects; D009504:Neutrophils / Q000187:drug effects
chemical_list: D016179:Granulocyte Colony-Stimulating Factor; D004317:Doxorubicin; D005472:Fluorouracil; D008727:Methotrexate